GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 56 filers reported holding GT BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,219 | -71.0% | 88,009 | -62.5% | 0.00% | – |
| Q2 2023 | $73,275 | +92653.2% | 234,857 | +64.3% | 0.00% | – |
| Q1 2023 | $79 | -33.1% | 142,927 | +8.4% | 0.00% | – |
| Q4 2022 | $118 | -100.0% | 131,905 | -14.3% | 0.00% | – |
| Q3 2022 | $271,000 | -62.9% | 153,979 | -36.9% | 0.00% | – |
| Q2 2022 | $730,000 | +217.4% | 244,180 | +615.5% | 0.00% | – |
| Q3 2021 | $230,000 | +20.4% | 34,127 | +22.3% | 0.00% | – |
| Q1 2021 | $191,000 | – | 27,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
| Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
| UBS Group AG | 8,750 | $2,109 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
| FMR LLC | 150 | $36 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
| NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |